Nubain, Nalbuphine Newswire
Comprehensive Real-Time News Feed for Nubain, Nalbuphine (generic).
Results 1 - 3 of 3 in Nubain, Nalbuphine (generic)
Trevi Therapeutics, Inc. , a clinical stage biotechnology company focused on developing Nalbuphine ER for chronic pruritus, presented data on nalbuphine at the 7th World Congress on Itch. Comment?
Nalbuphine is a mixed mu antagonist/kappa agonist opioid. The effect of nalbuphine on substance P induced scratching was studied by Trevi in the mouse model. Comment?
Editor at Pain & Central Nervous System Week -- Research findings on Analgesics are discussed in a new report. Comment?
- « Previous
- Next »